Henry Ford Cancer Institute/Henry Ford Health System — Detroit, Michigan

Henry Ford Cancer Institute/Henry Ford Health System is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Institute/Henry Ford Health System has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Non Small Cell Lung Cancer, KRAS Activating Mutation, Melanoma.

Sponsors: Verastem, Inc., Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Institute/Henry Ford Health System?

Henry Ford Cancer Institute/Henry Ford Health System has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Institute/Henry Ford Health System conducted?

Henry Ford Cancer Institute/Henry Ford Health System has 2 clinical trials on record, with 1 currently active. Their work covers Non Small Cell Lung Cancer, KRAS Activating Mutation, Melanoma.

Is Henry Ford Cancer Institute/Henry Ford Health System accredited by Crixeo Health?

Henry Ford Cancer Institute/Henry Ford Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer Institute/Henry Ford Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.